Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant Tuberculosis in Viet Nam

Authors: Dang Thi Minh Ha, Nguyen Thi Ngoc Lan, Marcel Wolbers, Vo sy Kiet, Hoang Thi Thanh Hang, Nguyen Hong Duc, To My Huong, Vuong Minh Bach, Nguyen Thi Phuong Thao, Tran Van Quyet, Nguyen Thi Bich Tuyen, Vo Thi Ha, Nguyen Thi Nho, Dai Viet Hoa, Phan Thi Hoang Anh, Nguyen Huy Dung, Jeremy Farrar, Maxine Caws

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

Early diagnosis of tuberculosis (TB) and multidrug resistant tuberculosis (MDR TB) is important for the elimination of TB. We evaluated the microscopic observation drug susceptibility (MODS) assay as a direct rapid drug susceptibility testing (DST) method for MDR-TB screening in sputum samples

Methods

All adult TB suspects, who were newly presenting to Pham Ngoc Thach Hospital from August to November 2008 were enrolled into the study. Processed sputum samples were used for DST by MODS (DST-MODS) (Rifampicin (RIF) 1 μg/ml and Isoniazid (INH) 0.4 μg/ml), MGIT culture (Mycobacterial Growth Indicator Tube) and Lowenstein Jensen (LJ) culture. Cultures positive by either MGIT or LJ were used for proportional DST (DST-LJ) (RIF 40 μg/ml and INH 0.2 μg/ml). DST profiles on MODS and LJ were compared. Discrepant results were resolved by multiplex allele specific PCR (MAS-PCR).

Results

Seven hundred and nine TB suspects/samples were enrolled into the study, of which 300 samples with DST profiles available from both MODS and DST-LJ were analyzed. Cording in MODS was unable to correctly identify 3 Mycobacteria Other Than Tuberculosis (MOTT) isolates, resulting in 3 false positive TB diagnoses. None of these isolates were identified as MDR-TB by MODS. The sensitivity and specificity of MODS were 72.6% (95%CI: 59.8, 83.1) and 97.9% (95%CI: 95.2, 99.3), respectively for detection of INH resistant isolates, 72.7% (95%CI: 30.9, 93.7) and 99.7% (95%CI: 98.1, 99.9), respectively for detecting RIF resistant isolates and 77.8% (95%CI: 39.9, 97.1) and 99.7% (95%CI: 98.1, 99.9), respectively for detecting MDR isolates. The positive and negative predictive values (PPV and NPV) of DST-MODS were 87.5% (95%CI: 47.3, 99.6) and 99.3% (95%CI: 97.5, 99.9) for detection of MDR isolates; and the agreement between MODS and DST-LJ was 99.0% (kappa: 0.8, P < 0.001) for MDR diagnosis. The low sensitivity of MODS for drug resistance detection was probably due to low bacterial load samples and the high INH concentration (0.4 μg/ml). The low PPV of DST-MODS may be due to the low MDR-TB rate in the study population (3.8%). The turnaround time of DST-MODS was 9 days and 53 days for DST-LJ.

Conclusion

The DST-MODS technique is rapid with low contamination rates. However, the sensitivity of DST-MODS for detection of INH and RIF resistance in this study was lower than reported from other settings.
Appendix
Available only for authorised users
Literature
2.
go back to reference Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J: Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010, 375 (9728): 1830-1843. 10.1016/S0140-6736(10)60410-2.CrossRefPubMed Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J: Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010, 375 (9728): 1830-1843. 10.1016/S0140-6736(10)60410-2.CrossRefPubMed
7.
go back to reference Kremer K, van Soolingen D, Frothingham R, Haas WH, Hermans PW, Martin C, Palittapongarnpim P, Plikaytis BB, Riley LW, Yakrus MA, et al: Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol. 1999, 37 (8): 2607-2618.PubMedPubMedCentral Kremer K, van Soolingen D, Frothingham R, Haas WH, Hermans PW, Martin C, Palittapongarnpim P, Plikaytis BB, Riley LW, Yakrus MA, et al: Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol. 1999, 37 (8): 2607-2618.PubMedPubMedCentral
8.
go back to reference Minion J, Leung E, Menzies D, Pai M: Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2010, 10 (10): 688-698. 10.1016/S1473-3099(10)70165-1.CrossRefPubMed Minion J, Leung E, Menzies D, Pai M: Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2010, 10 (10): 688-698. 10.1016/S1473-3099(10)70165-1.CrossRefPubMed
11.
go back to reference Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, et al: Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010, 363 (11): 1005-1015. 10.1056/NEJMoa0907847.CrossRefPubMedPubMedCentral Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, et al: Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010, 363 (11): 1005-1015. 10.1056/NEJMoa0907847.CrossRefPubMedPubMedCentral
12.
go back to reference Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W: Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med. 2011, 8 (7): e1001061-10.1371/journal.pmed.1001061.CrossRefPubMedPubMedCentral Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W: Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med. 2011, 8 (7): e1001061-10.1371/journal.pmed.1001061.CrossRefPubMedPubMedCentral
14.
go back to reference Ejigu GS, Woldeamanuel Y, Shah NS, Gebyehu M, Selassie A, Lemma E: Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int J Tuberc Lung Dis. 2008, 12 (3): 332-337.PubMed Ejigu GS, Woldeamanuel Y, Shah NS, Gebyehu M, Selassie A, Lemma E: Microscopic-observation drug susceptibility assay provides rapid and reliable identification of MDR-TB. Int J Tuberc Lung Dis. 2008, 12 (3): 332-337.PubMed
15.
go back to reference Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, Sanchez E, Pinedo Y, Saravia JC, Salazar C, et al: Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med. 2006, 355 (15): 1539-1550. 10.1056/NEJMoa055524.CrossRefPubMedPubMedCentral Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, Sanchez E, Pinedo Y, Saravia JC, Salazar C, et al: Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med. 2006, 355 (15): 1539-1550. 10.1056/NEJMoa055524.CrossRefPubMedPubMedCentral
16.
go back to reference Moore DA, Mendoza D, Gilman RH, Evans CA, Hollm Delgado MG, Guerra J, Caviedes L, Vargas D, Ticona E, Ortiz J, et al: Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol. 2004, 42 (10): 4432-4437. 10.1128/JCM.42.10.4432-4437.2004.CrossRefPubMedPubMedCentral Moore DA, Mendoza D, Gilman RH, Evans CA, Hollm Delgado MG, Guerra J, Caviedes L, Vargas D, Ticona E, Ortiz J, et al: Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol. 2004, 42 (10): 4432-4437. 10.1128/JCM.42.10.4432-4437.2004.CrossRefPubMedPubMedCentral
18.
go back to reference Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A: Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010, 375 (9729): 1920-1937. 10.1016/S0140-6736(10)60359-5.CrossRefPubMed Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A: Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010, 375 (9729): 1920-1937. 10.1016/S0140-6736(10)60359-5.CrossRefPubMed
19.
go back to reference Tran NB, Houben RM, Hoang TQ, Nguyen TN, Borgdorff MW, Cobelens FG: HIV and tuberculosis in Ho Chi Minh City, Vietnam, 1997-2002. Emerg Infect Dis. 2007, 13 (10): 1463-1469.PubMed Tran NB, Houben RM, Hoang TQ, Nguyen TN, Borgdorff MW, Cobelens FG: HIV and tuberculosis in Ho Chi Minh City, Vietnam, 1997-2002. Emerg Infect Dis. 2007, 13 (10): 1463-1469.PubMed
22.
go back to reference Ha DT, Lan NT, Kiet VS, Wolbers M, Hang HT, Day J, Hien NQ, Tien NA, An PT, Anh TT, et al: Diagnosis of pulmonary tuberculosis in HIV-positive patients by microscopic observation drug susceptibility assay. J Clin Microbiol. 2010, 48 (12): 4573-4579. 10.1128/JCM.00687-10.CrossRefPubMedPubMedCentral Ha DT, Lan NT, Kiet VS, Wolbers M, Hang HT, Day J, Hien NQ, Tien NA, An PT, Anh TT, et al: Diagnosis of pulmonary tuberculosis in HIV-positive patients by microscopic observation drug susceptibility assay. J Clin Microbiol. 2010, 48 (12): 4573-4579. 10.1128/JCM.00687-10.CrossRefPubMedPubMedCentral
24.
go back to reference Ha DT, Lan NT, Wolbers M, Duong TN, Quang ND, Thi Van Thinh T, Thi Hong Ngoc L, Thi Ngoc Anh N, Van Quyet T, Thi Bich Tuyen N, et al: Microscopic observation drug susceptibility assay (MODS) for early diagnosis of tuberculosis in children. PLoS One. 2009, 4 (12): e8341-10.1371/journal.pone.0008341.CrossRefPubMedPubMedCentral Ha DT, Lan NT, Wolbers M, Duong TN, Quang ND, Thi Van Thinh T, Thi Hong Ngoc L, Thi Ngoc Anh N, Van Quyet T, Thi Bich Tuyen N, et al: Microscopic observation drug susceptibility assay (MODS) for early diagnosis of tuberculosis in children. PLoS One. 2009, 4 (12): e8341-10.1371/journal.pone.0008341.CrossRefPubMedPubMedCentral
25.
go back to reference Honore-Bouakline S, Vincensini JP, Giacuzzo V, Lagrange PH, Herrmann JL: Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J Clin Microbiol. 2003, 41 (6): 2323-2329. 10.1128/JCM.41.6.2323-2329.2003.CrossRefPubMedPubMedCentral Honore-Bouakline S, Vincensini JP, Giacuzzo V, Lagrange PH, Herrmann JL: Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J Clin Microbiol. 2003, 41 (6): 2323-2329. 10.1128/JCM.41.6.2323-2329.2003.CrossRefPubMedPubMedCentral
27.
go back to reference Tho DQ, Ha DT, Duy PM, Lan NT, Hoa DV, Chau NV, Farrar J, Caws M: Comparison of MAS-PCR and GenoType MTBDR assay for the detection of rifampicin-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2008, 12 (11): 1306-1312.PubMed Tho DQ, Ha DT, Duy PM, Lan NT, Hoa DV, Chau NV, Farrar J, Caws M: Comparison of MAS-PCR and GenoType MTBDR assay for the detection of rifampicin-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2008, 12 (11): 1306-1312.PubMed
28.
go back to reference Tho DQ, Lan NT, Chau NV, Farrar J, Caws M: Multiplex allele-specific polymerase chain reaction for detection of isoniazid resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2011, 15 (6): 799-803. 10.5588/ijtld.10.0599.CrossRefPubMed Tho DQ, Lan NT, Chau NV, Farrar J, Caws M: Multiplex allele-specific polymerase chain reaction for detection of isoniazid resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2011, 15 (6): 799-803. 10.5588/ijtld.10.0599.CrossRefPubMed
29.
go back to reference Zhang Y, Yew WW: Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2009, 13 (11): 1320-1330.PubMed Zhang Y, Yew WW: Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2009, 13 (11): 1320-1330.PubMed
31.
go back to reference Guo H, Seet Q, Denkin S, Parsons L, Zhang Y: Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J Med Microbiol. 2006, 55 (Pt 11): 1527-1531.CrossRefPubMed Guo H, Seet Q, Denkin S, Parsons L, Zhang Y: Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J Med Microbiol. 2006, 55 (Pt 11): 1527-1531.CrossRefPubMed
32.
go back to reference Mello FC, Arias MS, Rosales S, Marsico AG, Pavon A, Alvarado-Galvez C, Pessoa CL, Perez M, Andrade MK, Kritski AL, et al: Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol. 2007, 45 (10): 3387-3389. 10.1128/JCM.00580-07.CrossRefPubMedPubMedCentral Mello FC, Arias MS, Rosales S, Marsico AG, Pavon A, Alvarado-Galvez C, Pessoa CL, Perez M, Andrade MK, Kritski AL, et al: Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol. 2007, 45 (10): 3387-3389. 10.1128/JCM.00580-07.CrossRefPubMedPubMedCentral
Metadata
Title
Evaluation of microscopic observation drug susceptibility assay for diagnosis of multidrug-resistant Tuberculosis in Viet Nam
Authors
Dang Thi Minh Ha
Nguyen Thi Ngoc Lan
Marcel Wolbers
Vo sy Kiet
Hoang Thi Thanh Hang
Nguyen Hong Duc
To My Huong
Vuong Minh Bach
Nguyen Thi Phuong Thao
Tran Van Quyet
Nguyen Thi Bich Tuyen
Vo Thi Ha
Nguyen Thi Nho
Dai Viet Hoa
Phan Thi Hoang Anh
Nguyen Huy Dung
Jeremy Farrar
Maxine Caws
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-49

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.